Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum

Abstract

DMPA, which is an effective contraceptive agent, can be used to prevent bleeding from the corpus luteum by means of ovulation suppression in anticoagulated patients with prosthetic heart valves. However, meticulous surveillance should be provided during the follow-up, including close monitoring of anticoagulation intensity and lipid profile.